Senior Director, Clinical Operations

About Century Therapeutics:
Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases, including type 1 diabetes, and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies, which will ultimately advance the course of care.

Role:

The successful candidate will:

•Lead day-to-day execution of Type 1 diabetes cell therapy clinical studies from start-up through close-out.

•Coordinate endocrinology, transplant, specialty-site, CRO, vendor, and investigational product activities to support treatment readiness and high-quality study conduct.

•Oversee operational planning, procedural workflows, study documentation, and issue resolution.

•Serve as a key cross-functional operational partner across Clinical Development, Clinical Operations, Translational Medicine, CMC, Quality, Regulatory, Safety, sites, CROs, and vendors; Lead clinical study team meetings.

The work expectation for this role is 1-2 days on-site (preferred).

The expected annual salary range for this role is approximately $240,000 - $270,000 depending on experience. Additional benefits offered include but are not limited to an annual performance-based bonus (prorated by start date), medical, dental, and vision insurance, matching 401K plan, and 20+ days per-year of PTO (prorated by start date). Additionally, employees not requiring sponsorship are preferred.